Immunizations for patients with metabolic disorders

被引:20
作者
Kingsley, Jeffrey D.
Varman, Meera
Chatterjee, Archana
Kingsley, Rae A.
Roth, Karl S. [1 ]
机构
[1] Creighton Univ, Med Ctr, Dept Pediat, Omaha, NE 68131 USA
[2] Creighton Univ, Med Ctr, Combined Div Metab, Omaha, NE 68131 USA
[3] Univ Nebraska, Med Ctr, Div Pediat Infect Dis, Lincoln, NE 68583 USA
[4] Childrens Hosp, Omaha, NE USA
关键词
immunizations; vaccines; metabolic diseases/disorders; public health;
D O I
10.1542/peds.2005-1257
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Individuals with underlying metabolic disorders are a potential high-risk group for vaccine-preventable diseases. Newborn metabolic screening has provided a means of early identification and treatment for many of these disorders, whereas childhood immunization is one of the most effective means of decreasing the morbidity and mortality resulting from communicable diseases worldwide. There are very few contraindications to the routine administration of vaccines to the healthy, immunocompetent individual. In certain high-risk groups, such as immunocompromised patients, gravid females, and those with a history of previous anaphylactic reaction to a vaccine or its components, selective withholding of immunizations must be considered to decrease potential adverse events. A detailed analysis of the medical literature revealed few specific recommendations regarding appropriate immunization techniques for patients with metabolic disorders. In this review we detail the major metabolic disorder subtypes, elaborate on the available literature on immunizations for patients with these disorders, and provide suggested vaccine recommendations.
引用
收藏
页码:E460 / E470
页数:11
相关论文
共 42 条
  • [1] Effective immunoglobulin therapy for brief tonic seizures in methylmalonic acidemia
    Aikoh, H
    Sasaki, M
    Sugai, K
    Yoshida, H
    Sakuragawa, N
    [J]. BRAIN & DEVELOPMENT, 1997, 19 (07) : 502 - 505
  • [2] Glutaric aciduria type I diagnosed after poliovirus immunization: Magnetic resonance findings
    Alkan, A
    Baysal, T
    Yakinci, C
    Sigirci, A
    Kutlu, R
    [J]. PEDIATRIC NEUROLOGY, 2002, 26 (05) : 405 - 407
  • [3] *AM AC PED, 2003, 2003 RED BOOK REP CO, P82
  • [4] *AM AC PED, 2003, 2003 RED BOOK REP CO, P484
  • [5] SHORT-CHAIN ACYL-COENZYME-A DEHYDROGENASE-DEFICIENCY - CLINICAL AND BIOCHEMICAL-STUDIES IN 2 PATIENTS
    AMENDT, BA
    GREENE, C
    SWEETMAN, L
    CLOHERTY, J
    SHIH, V
    MOON, A
    TEEL, L
    RHEAD, WJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (05) : 1303 - 1309
  • [6] Medium-chain Acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-Based prospective screening of newborns differ from those observed in patients with clinical symptoms: Identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency
    Andresen, BS
    Dobrowolski, SF
    O'Reilly, L
    Muenzer, J
    McCandless, SE
    Frazier, DM
    Udvari, S
    Bross, P
    Knudsen, I
    Banas, R
    Chace, DH
    Engel, P
    Naylor, EW
    Gregersen, N
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (06) : 1408 - 1418
  • [7] ATKINSON W, 2004, EPIDEMIOLOGY PREVENT
  • [8] METABOLIC EFFECTS OF INTRACELLULAR INFECTIONS IN MAN
    BEISEL, WR
    SAWYER, WD
    RYLL, ED
    CROZIER, D
    [J]. ANNALS OF INTERNAL MEDICINE, 1967, 67 (04) : 744 - +
  • [9] BEISEL WR, 2004, TXB PEDIAT INFECT DI, P62
  • [10] SPHINGOLIPIDOSES
    BRADY, RO
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1966, 275 (06) : 312 - &